1-3 of 3
Peter Senter, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

SGN-CD30C, an Investigational CD30-Directed Camptothecin Antibody-Drug Conjugate (ADC), Shows Strong Anti Tumor Activity and Superior Tolerability in Preclinical Studies

Maureen Ryan, Ryan Lyski, Lauren Bou, Ryan Heiser, Bryan Grogan, Dave Meyer, Steven Jin, Jessica Simmons, Melissa Conerly, Peter Senter, PhD, Scott Jeffrey
Journal: Blood
Blood (2020) 136 (Supplement 1): 41–42.
https://doi.org/10.1182/blood-2020-136577
Published: 2020
Journal Articles

SGN-CD123A, a Pyrrolobenzodiazepine Dimer Linked Anti-CD123 Antibody Drug Conjugate, Demonstrates Effective Anti-Leukemic Activity in Multiple Preclinical Models of AML

May S.K. Sutherland, PhD, Changpu Yu, Roland B. Walter, MD PhD, Lori Westendorf, John Valliere-Douglass, PhD, Lucy Pan, PhD, Django Sussman, PhD, Martha Anderson, Weiping Zeng, Ivan Stone, Kerry Klussman, Michelle Ulrich, Mechthild Jonas, PhD, Peter Senter, PhD, Jonathan G. Drachman, MD, Dennis Benjamin, PhD
Journal: Blood
Blood (2015) 126 (23): 330.
https://doi.org/10.1182/blood.V126.23.330.330
Published: 2015
Journal Articles

Supression of FLT3-Expressing Leukemia by a Monoclonal Antibody-Auristatin Conjugate.

Yiwen Li, MD, Hongli Li, Mei-Nai Wang, Rajiv Bassi, Dale Ludwig, PhD, Larry Witte, PhD, Zhenping Zhu, MD, PhD, Peter Bohlen, PhD, Damon Meyer, PhD, Angelyn Larkin, Peter Senter, PhD, Daniel Hicklin, PhD
Journal: Blood
Blood (2004) 104 (11): 1788.
https://doi.org/10.1182/blood.V104.11.1788.1788
Published: 2004